NCT06086665 2026-02-04
REFIRM
Asan Medical Center
Completed
Clinical Trials
12 trialsNCT07059676 2025-07-11
LIBINI-1
Clinica Universidad de Navarra, Universidad de Navarra
Not yet recruiting
NCT06827353 2025-02-14
OVNI-B
Centre Hospitalier Universitaire de Nīmes
Recruiting
NCT06614790 2024-10-23
NIRAPARIB
Pomeranian Medical University Szczecin
Recruiting
NCT04774406 2023-06-06
Arterial Hypertension Related to PARP Inhibitors (ArteRIB)
University Hospital, Caen
Completed
NCT05734911 2023-02-21
Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study
Zhongda Hospital
Completed
NCT04295577 2022-01-21
MONITOR-UK
Royal Marsden NHS Foundation Trust
Unknown
NCT04774627 2021-09-23
Pancytopenia Related to PARP Inhibitors (PancytoRIB)
University Hospital, Caen
Completed
NCT05044091 2021-09-14
HOPEI
Jiangsu Cancer Institute & Hospital
Unknown
NCT04546373 2021-08-05
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario
Completed
NCT04785716 2021-03-08
Real-life Use of Niraparib in a Patient Access Program in Norway
Oslo University Hospital
Completed
NCT04582552 2021-01-20
ROMP
Jiangsu Cancer Institute & Hospital
Unknown